Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Yifeng Pharmacy Chain (603939 CH)
Watchlist
37
Analysis
Consumer Staples
•
China
Yifeng Pharmacy Chain Co., Ltd. operates as a chain of retail stores that specialize in pharmaceutical and over the counter remedies and personal care products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Beijing Yuanxin Technology Group Co Ltd
•
15 Feb 2024 08:55
Pre-IPO Beijing Yuanxin Technology Group (PHIP Update) - Risk of Overvaluation and Poor Profit Model
The dilemma of single revenue model and excessive reliance on drug sales is hard to overcome.Due to low gross margin, it's difficult to generate...
Xinyao (Criss) Wang
Follow
367 Views
Share
bearish
•
Quantitative Analysis
•
08 Jan 2024 09:00
Northbound Flows (December): Five Months of Outflows
We analyzed the Shanghai/Shenzhen Connect Scheme for December and highlight flows for CATL, Mindray, Will Semi, BYD, Wuxi Apptec, CMB, Wuliangye,...
Ke Yan, CFA, FRM
Follow
321 Views
Share
bearish
•
Quantitative Analysis
•
04 Dec 2023 10:05
Northbound Flows (November): Inflows (Consumer Staples, Healthcare) Offset by Outflows (Financials)
We analyzed the Shanghai/Shenzhen Connect Scheme for November and highlight flows for Moutai, Hygon Information Technology, Shanghai United Imaging...
Ke Yan, CFA, FRM
Follow
387 Views
Share
bearish
•
Beijing Yuanxin Technology Group Co Ltd
•
26 Sep 2023 08:55
Pre-IPO Beijing Yuanxin Technology Group - Some Points Worth the Attention
Yuanxin has weak profitability. It's questionable whether investors can achieve expected returns on this company.We think Yuanxin may eventually be...
Xinyao (Criss) Wang
Follow
397 Views
Share
bullish
•
Guangzhou Baiyunshan Pharmaceu
•
28 Jun 2023 08:55
Guangzhou Baiyunshan Pharmaceutical (874.HK) - When Valuation Is Low Enough, Drawbacks Are Tolerable
Due to the special "positioning" of Baiyunshan's business, the market's enthusiasm for the company is not high. But when its valuation is low...
Xinyao (Criss) Wang
Follow
304 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x